{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:10:51Z","timestamp":1792084251455,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS111655"],"award-info":[{"award-number":["NS111655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG005131"],"award-info":[{"award-number":["P50 AG005131"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.parkreldis.2021.04.017","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T02:52:48Z","timestamp":1619578368000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-2239","authenticated-orcid":false,"given":"Georgia M.","family":"Parkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Corey-Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Castleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.parkreldis.2021.04.017_bib1","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.04.017_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","article-title":"The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset","volume":"71","author":"Andresen","year":"2007","journal-title":"Ann. Hum. Genet."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.04.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.04.017_bib4","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"Vinther-Jensen","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"574","key":"10.1016\/j.parkreldis.2021.04.017_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc2888","article-title":"Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease","volume":"12","author":"Rodrigues","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.04.017_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"issue":"458","key":"10.1016\/j.parkreldis.2021.04.017_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7108","article-title":"Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease","volume":"10","author":"Byrne","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.04.017_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2008.05.012","article-title":"Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.04.017_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","article-title":"Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis","volume":"19","author":"Scahill","year":"2020","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.04.017_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.04.017_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.04.017_bib12","first-page":"136","article-title":"Unified Huntington's disease rating scale: reliability and consistency","volume":"11","author":"Kieburtz","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.04.017_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jcph.1598","article-title":"Huntington\u2019s disease progression: a population modeling approach to characterization using clinical rating scales","volume":"60","author":"Sun","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.04.017_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.04.017_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2021.04.017_bib16","series-title":"A Compendium of Neuropsychological Tests","article-title":"Symbol digit modalities test","author":"Smith","year":"1982"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.04.017_bib17","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Cognit. Behav. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.04.017_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.04.017_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ajmg.b.31232","article-title":"Indexing disease progression at study entry with individuals at\u2010risk for Huntington disease","volume":"156","author":"Zhang","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"24","key":"10.1016\/j.parkreldis.2021.04.017_bib20","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"Schobel","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.04.017_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","article-title":"Basal ganglia volume and proximity to onset in presymptomatic Huntington disease","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.04.017_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"PREDICT\u2010HD Investigators, CAG\u2010repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153","author":"Langbehn","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"320","key":"10.1016\/j.parkreldis.2021.04.017_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/01621459.1967.10500925","article-title":"Rank analysis of covariance","volume":"62","author":"Quade","year":"1967","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.parkreldis.2021.04.017_bib24","series-title":"Practical Nonparametric Statistics","author":"Conover","year":"1980"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.04.017_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light\u2014which is the more suitable biomarker for Huntington's disease?","volume":"12","author":"Niemel\u00e4","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.04.017_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JHD-140115","article-title":"Understanding the outcomes measures used in Huntington disease pharmacological trials: a systematic review","volume":"3","author":"Carlozzi","year":"2014","journal-title":"J Huntingtons Dis"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.04.017_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.parkreldis.2021.04.017_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","article-title":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease","volume":"58","author":"Pereira","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"15","key":"10.1016\/j.parkreldis.2021.04.017_bib29","doi-asserted-by":"crossref","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","article-title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","volume":"91","author":"Steinacker","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.04.017_bib30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J. Clin. Invest."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:17:42Z","timestamp":1778519862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"alternative-id":["S1353802021001504"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.04.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}